SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-024071
Filing Date
2023-05-25
Accepted
2023-05-25 08:16:19
Documents
12
Period of Report
2023-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20230522.htm   iXBRL 8-K 63834
  Complete submission text file 0000950170-23-024071.txt   193117

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20230522.xsd EX-101.SCH 2501
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20230522_pre.xml EX-101.PRE 11578
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20230522_lab.xml EX-101.LAB 18527
6 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20230522_htm.xml XML 4901
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 23956252
SIC: 2834 Pharmaceutical Preparations